Extensive finance modeling experience including development of valuations scenarios for companies in the rapidly growing infectious disease market. Performed primary and secondary research in the equity markets to inform investment decisions. Researched patient engagement trends in healthcare. Worked for Navigant consulting, Pfizer Global Supply Group, and PropThink LLC.

Read more

Mr. Sascha Bucher is co-founder and Partner at Forty51 ventures, a Biotech VC fund in Europe focused on venture formation. Previously, he was Partner and Managing Director Investments at Roivant Sciences and Head of Europe. Before that Sascha worked for Roche in numerous Business and Corporate Development functions including as Deputy Head of Global M&A. […]

Read more

18 years of experience in the Pharmaceutical and MedTech industries. U.S. regional and global leadership positions in Marketing, Business Development and General Management at BMS, Grünenthal, and the Getinge Group . Strong marketing background complemented by extensive experience in complex M&A and Partnership projects in both the U.S. and international settings. As well as general […]

Read more

20 years of experience in the pharma/biotech industry. CBO at Besins Healthcare (completed 15 deals in the past 3 years), VP BD/AM at Avadel Pharmaceuticals and Director of BD at Micromet (now Amgen). Founding CEO of Avidis (now Imaxio/Osivax) and BoD Member-liquidator of Aptanomics. Binational Ph.D. (France/Canada) and post-doctoral research at the Laboratory of Molecular […]

Read more

21 years of global corporate and business development experience in the pharmaceutical and biotech industries. Head of commercial operations and business development for Bristol-Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years. Series 79 FINRA Registered Rep.

Read more

TYPE & ENTER: